Gut microbiota and lung fibrosis
Growing evidence supports a gut-lung axis: a connection between the gut, including its microorganisms (microbiota), and lung disease outcomes.
Study finds RSV may evade vaccines via rapid mutation
For most people, respiratory syncytial virus (RSV) is about as dangerous as the common cold. But for children younger than 6 months old, and for people whose immune defenses have been weakened by age, disease, chemotherapy or transplantation, RSV can be fatal.
Researchers discover how salt increases blood pressure
A Vanderbilt research team has discovered that activation of a certain protein complex involved in the inflammatory response in immune ce
American Society for Clinical Investigation honors 10 Vanderbilt physicians
Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical
Dooley honored by Treatment Action Group
Kelly Dooley, MD, PhD, MPH, professor of Medicine and Pathology, Microbiology and Immunology, who recently joined Vanderbilt University Medical Center as director of the Division of Infectious Diseases, has received the Research in Action Award from the Treatment Action Group (TAG).
Emerging Infections Program lands national award for COVID response
The Tennessee Emerging Infections Program (EIP) was recently recognized with the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
COVID alters respiratory microbiota
Justin Turner, MD, PhD, Suman Das, PhD, and colleagues used ribosomal RNA gene sequencing to analyze the URT microbiota in serial nasal swab samples over 21 days from adults with mild-to-moderate COVID-19.